AAAAAA
Results:
1-25
|
Results: 25
Authors:
van Aken, WG
Citation: Wg. Van Aken, Principles of supportive haemotherapy, DEV HEMATOL, 33, 1998, pp. 3-7
Authors:
Murphy, WG
Citation: Wg. Murphy, What should trigger a transfusion?, DEV HEMATOL, 33, 1998, pp. 9-15
Authors:
Laupacis, A
Fergusson, D
Citation: A. Laupacis et D. Fergusson, The efficacy of technologies to minimise peri-operative allogeneic transfusion, DEV HEMATOL, 33, 1998, pp. 17-36
Authors:
de Wolf, JTM
Citation: Jtm. De Wolf, Evidence-based transfusion medicine or the need to evaluate clinical outcome, DEV HEMATOL, 33, 1998, pp. 37-42
Authors:
Fratantoni, JC
Sibinga, CTS
Spence, RK
Murphy, W
van Aken, WG
Laupacis, A
de Wolf, JTM
AuBuchon, JP
Lust, A
de Wit, HJC
Tahhan, HR
van Heukelom, LHS
Valeri, CR
Citation: Jc. Fratantoni et al., The clinical setting: How to optimise supportive haemotherapy - Discussion, DEV HEMATOL, 33, 1998, pp. 43-52
Authors:
Winslow, RM
Citation: Rm. Winslow, The role of O-2 transport in the development of the transfusion trigger, DEV HEMATOL, 33, 1998, pp. 55-73
Authors:
Goodnough, LT
Citation: Lt. Goodnough, Recombinant human erythropoietin - Could it be used in a better way?, DEV HEMATOL, 33, 1998, pp. 75-79
Authors:
Schroder, CP
van der Graaf, WTA
Willemse, PHB
Vellenga, E
de Leij, L
Mulder, NH
de Vries, EGE
Citation: Cp. Schroder et al., The impact of haematopoietic growth factors on supportive care in clinicaloncology: With special attention to potential tumour cell contamination inthe stem cell harvest, DEV HEMATOL, 33, 1998, pp. 81-95
Authors:
Middleton, SM
Citation: Sm. Middleton, The development of Synthocytes (TM), a novel platelet substitute, DEV HEMATOL, 33, 1998, pp. 97-102
Authors:
Helfrich, W
Kroesen, BJ
Molema, G
de Leij, L
Citation: W. Helfrich et al., Recent developments in the construction of bispecific antibodies, DEV HEMATOL, 33, 1998, pp. 103-118
Authors:
Nicolson, DM
Citation: Dm. Nicolson, Re-appraising the waste status of buffy coats: Natural human interferon, DEV HEMATOL, 33, 1998, pp. 119-122
Authors:
Valeri, CR
de Wit, HJC
Sibinga, CTS
de Vries, EGE
AuBuchon, JP
Winslow, RM
Boralessa, H
Fratantoni, JC
Middleton, S
de Leij, L
Goodnough, LT
Nicolson, DM
Lust, A
Citation: Cr. Valeri et al., Chemical and biological alternatives - Discussion, DEV HEMATOL, 33, 1998, pp. 123-131
Authors:
Baele, PL
Fraselle, B
Gouverneur, JM
de Kock, M
Citation: Pl. Baele et al., Volume: A matter of replacement, DEV HEMATOL, 33, 1998, pp. 135-145
Authors:
Spence, RK
Citation: Rk. Spence, The management of anaemia in the surgical patient: What's new?, DEV HEMATOL, 33, 1998, pp. 147-159
Authors:
Koopman-van Gemert, AWMM
Citation: Awmm. Koopman-van Gemert, How to save blood: Alternative approaches in anaesthesiology and surgery, DEV HEMATOL, 33, 1998, pp. 161-166
Authors:
Fergusson, D
Graham, ID
Laupacis, A
Citation: D. Fergusson et al., The use of technologies to decrease perioperative allogeneic blood transfusion: An international survey of practice, DEV HEMATOL, 33, 1998, pp. 167-174
Authors:
Jacobs, HCJM
Falkenburg, JHF
Citation: Hcjm. Jacobs et Jhf. Falkenburg, Umbilical cord blood as an alternative source of haematopoietic stem cellsfor transplantation, DEV HEMATOL, 33, 1998, pp. 175-181
Authors:
Gluckman, E
Rocha, V
Chastang, C
Citation: E. Gluckman et al., Cord blood banking and transplant in Europe, DEV HEMATOL, 33, 1998, pp. 183-196
Authors:
Goodnough, LT
de Wit, HJC
Fratantoni, JC
Baele, P
Rocha, V
Elias, MK
Falkenburg, F
Spence, RK
Koopman-van Gemert, AWMM
Sibinga, CTS
Fergusson, D
McClelland, DBL
AuBuchon, JP
Citation: Lt. Goodnough et al., Alternative approaches in clinical practice - Discussion, DEV HEMATOL, 33, 1998, pp. 197-205
Authors:
Valeri, CR
Crowley, P
Loscalzo, J
Citation: Cr. Valeri et al., Indications for red blood cell transfusion, DEV HEMATOL, 33, 1998, pp. 209-214
Authors:
AuBuchon, JP
Citation: Jp. Aubuchon, Cost-effectiveness of conventional and alternative approaches in transfusion practice: The value of decision analysis, DEV HEMATOL, 33, 1998, pp. 215-221
Authors:
Hebert, PC
Citation: Pc. Hebert, The design of transfusion in randomised controlled trials in critically ill patients, DEV HEMATOL, 33, 1998, pp. 223-238
Authors:
Fratantoni, JC
Citation: Jc. Fratantoni, The future of human blood resources, DEV HEMATOL, 33, 1998, pp. 239-243
Authors:
Fratantoni, JC
Das, PC
Laupacis, A
AuBuchon, JP
Brand, A
Hebert, PC
Sibinga, CTS
McClelland, B
Winslow, RM
Valeri, CR
Lust, A
Citation: Jc. Fratantoni et al., The balance of risks, benefits and costs - Discussion, DEV HEMATOL, 33, 1998, pp. 245-252
Authors:
van Rood, JJ
Citation: Jj. Van Rood, Alternative approaches to human blood resources in clinical practice - Proceedings of the Twenty-Second International Symposium on Blood Transfusion,Groningen 1997, organized by the Red Cross Blood Bank Noord Nederland - Foreword, DEV HEMATOL, 33, 1998, pp. XIII-XVI
Risultati:
1-25
|